Get the Stockscreener App
46.67
2.40%
-1.15
Pre-market:
46.95
0.28
+0.60%
Prestige Consumer Healthcare Inc stock is traded at $46.67, with a volume of 726.10K.
It is down -2.40% in the last 24 hours and down -0.17% over the past month.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
See More
Previous Close:
$47.82
Open:
$47.63
24h Volume:
726.10K
Relative Volume:
1.12
Market Cap:
$2.21B
Revenue:
$1.10B
Net Income/Loss:
$186.50M
P/E Ratio:
12.34
EPS:
3.7817
Net Cash Flow:
$267.19M
1W Performance:
-2.20%
1M Performance:
-0.17%
6M Performance:
-24.56%
1Y Performance:
-44.42%
1-Day Range:
$46.66
$49.50
1-Week Range:
$46.66
$49.81
52-Week Range:
$42.62
$85.29
Prestige Consumer Healthcare Inc Stock (PBH) Company Profile
Name
Prestige Consumer Healthcare Inc
Sector
Phone
(914) 524-6800
Address
660 WHITE PLAINS RD., TARRYTOWN, NY
Compare PBH vs TAK, HLN, TEVA, ZTS, UTHR
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PBH
Prestige Consumer Healthcare Inc
|
46.67 | 2.21B | 1.10B | 186.50M | 267.19M | 3.7817 |
TAK
Takeda Pharmaceutical Co Adr
|
15.77 | 49.83B | 29.91B | 1.30B | 3.49B | 0.4056 |
HLN
Haleon Plc Adr
|
9.07 | 40.04B | 14.54B | 2.22B | 2.58B | 0.4871 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
33.69 | 39.23B | 17.53B | 1.58B | 444.18M | 1.3457 |
ZTS
Zoetis Inc
|
79.95 | 33.52B | 9.51B | 2.64B | 2.14B | 6.0361 |
UTHR
United Therapeutics Corp
|
549.57 | 23.33B | 3.17B | 1.29B | 1.01B | 27.09 |
Prestige Consumer Healthcare Inc Stock (PBH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-24-25 | Upgrade | Sidoti | Neutral → Buy |
| Dec-09-24 | Downgrade | Sidoti | Buy → Neutral |
| Jun-21-24 | Upgrade | DA Davidson | Neutral → Buy |
| Nov-17-22 | Initiated | Canaccord Genuity | Buy |
| May-10-22 | Upgrade | Jefferies | Hold → Buy |
| May-09-22 | Upgrade | Oppenheimer | Perform → Outperform |
| Aug-07-20 | Downgrade | DA Davidson | Buy → Neutral |
| Jun-29-20 | Upgrade | Sidoti | Neutral → Buy |
| Apr-14-20 | Downgrade | Jefferies | Buy → Hold |
| Apr-07-20 | Resumed | Sidoti | Neutral |
| Mar-26-20 | Upgrade | Jefferies | Hold → Buy |
| Mar-24-20 | Initiated | Oppenheimer | Perform |
| Mar-19-20 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-15-19 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-04-17 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jun-02-17 | Upgrade | Jefferies | Underperform → Hold |
| May-22-17 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Dec-27-16 | Reiterated | B. Riley & Co. | Buy |
| Nov-17-16 | Initiated | Gabelli & Co | Buy |
| Aug-12-16 | Upgrade | Sidoti | Neutral → Buy |
| Mar-08-16 | Initiated | KeyBanc Capital Mkts | Overweight |
| Feb-05-16 | Initiated | Piper Jaffray | Overweight |
| Nov-30-15 | Downgrade | Jefferies | Hold → Underperform |
| Apr-28-14 | Reiterated | B. Riley & Co. | Buy |
| Apr-28-14 | Reiterated | Oppenheimer | Outperform |
| Jul-09-13 | Initiated | B. Riley & Co. | Buy |
View All
Prestige Consumer Healthcare Inc Stock (PBH) Latest News
Prestige Consumer Healthcare Secures $1.045 Billion Term Loan, Expands ABL to $225 Million - TradingView
Prestige Consumer (NYSE: PBH) uses $1.045B term loan to buy Breathe Right - Stock Titan
Prestige Consumer Healthcare Inc. Completes Acquisition of Breathe Right - Happi | Household And Personal Products Industry
Prestige Consumer Healthcare Stock (US74116D1037): Sector Check On A Quiet Trading Day - AD HOC NEWS
Prestige Consumer Healthcare completes $1.045 billion acquisition - Investing.com
Breathe Right nasal strips sold to Prestige in $1.045B deal - Stock Titan
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: Unveiling a 39.69% Potential Upside - DirectorsTalk Interviews
Does Earnings Miss, Weaker Outlook and Probe Into Disclosures Change The Bull Case For PBH? - Yahoo Finance
Why is Prestige Consumer Healthcare (PBH) up 3.6% since last earnings report? - MSN
Why Is Prestige Consumer Healthcare (PBH) Up 3.6% Since Last Earnings Report? - Yahoo Finance
PBH Investors Have Opportunity to Join Prestige Consumer Healthc - GuruFocus
PBH Investors Have Opportunity to Join Prestige Consumer Healthcare Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Prestige Consumer Healthcare Inc.PBH - PR Newswire
PBH Stock Price, Quote & Chart - ChartMill
Capital Research Global Investors Boosts Holdings in Prestige Consumer Healthcare Inc. $PBH - MarketBeat
Prestige Consumer Healthcare Inc. $PBH Position Raised by Brandes Investment Partners LP - MarketBeat
DEAN SMALL CAP VALUE's Prestige Consumer Healthcare Inc(PBH) Holding History - GuruFocus
PBH: Major acquisitions and disciplined strategy position for strong growth and international expansion - TradingView
Prestige Consumer Healthcare (PBH) Stock Analysis: A 41% Potential Upside Amid Strong Analyst Ratings - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc. Income Statement – NYSE:PBH - TradingView
How (PBH) Movements Inform Risk Allocation Models - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Prestige Consumer Healthcare Inc. (PBH) And Encourages Shareholders to Reach Out - ACCESS Newswire
Prestige Consumer Healthcare Inc. to Participate in the Oppenheimer Annual Consumer Growth and E-Commerce Conference - The Manila Times
Prestige Consumer Healthcare Inc. to Participate in the - GlobeNewswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare Inc. (PBH) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire
Zacks Research Brokers Reduce Earnings Estimates for PBH - MarketBeat
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein - The National Law Review
2026-06-03 | Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PBH | Press Release - Stockhouse
Is the options market predicting a spike in Prestige Consumer stock? - MSN
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer Healthcare Inc. (PBH) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Prestige Consumer Healthcare Inc. (PBH) And Encourages Investors to Connect - ACCESS Newswire
Why Canaccord Reduced Prestige Consumer Healthcare Inc. (PBH) Price Target After Q4 Weakness - Insider Monkey
Is the Options Market Predicting a Spike in Prestige Consumer Stock? - TradingView
Prestige Consumer Healthcare (PBH) Stock Analysis: Exploring a 40% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Bronstein, Gewirtz & Grossman, LLC Encourages Prestige Consumer Healthcare Inc. (PBH) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
11 Most Undervalued Pharma Stocks to Invest In - Insider Monkey
2026-05-31 | Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare (PBH) and Encourages Shareholders to Learn More About the Investigation | NYSE:PBH | Press Release - Stockhouse
PBH Q1 2026 Earnings: EPS Misses Estimates, Stock DeclinesConsensus Beat Rate - thelegaladvocate.com
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare Inc. (PBH) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
2026-05-29 | Prestige Consumer Healthcare (PBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation | NYSE:PBH | Press Release - Stockhouse
Prestige Consumer Healthcare (PBH) Insider Trading Activity 2026 $PBH - MarketBeat
Prestige Consumer Healthcare Inc. (PBH) Edges Higher Amid Defensive AppealFRAMA Signal - The Legal Advocate
2026-05-27 | Bronstein, Gewirtz & Grossman, LLC Is Investigating Prestige Consumer Healthcare (PBH) And Encourages Investors to Connect | NYSE:PBH | Press Release - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Is Investigating Prestige Consumer Healthcare Inc. (PBH) And Encourages Stockholders to Connect - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Is Investigating Prestige Cons - The National Law Review
Prestige Consumer Healthcare Inc. (PBH) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Trading Systems Reacting to (PBH) Volatility - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Prestige Consumer Healthcare Inc. (PBH) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
Prestige Consumer Healthcare Inc. (PBH) Stock Analysis: A 39% Upside Potential Amidst Strong Analyst Ratings - DirectorsTalk Interviews
Prestige Consumer Healthcare Inc Stock (PBH) Financials Data
Revenue
Net Income
Cash Flow
EPS
9.24%
0.23%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):